• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最大持续时间与信息量试验中序贯对数秩检验的设计与分析

Design and analysis of group sequential logrank tests in maximum duration versus information trials.

作者信息

Kim K, Boucher H, Tsiatis A A

机构信息

Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.

出版信息

Biometrics. 1995 Sep;51(3):988-1000.

PMID:7548714
Abstract

When monitoring a clinical trial with failure time data using the logrank test and the type I error spending function approach, the information time has to be estimated as a fraction of the maximum number of failures. In maximum duration trials, the denominator of this fraction is a random quantity and has to be estimated; besides, there are two candidates for the denominator, one under the null hypothesis of no treatment difference and the other under the specified alternative hypothesis. Either way, some adjustments are necessary in determining group sequential boundaries in order to maintain type I error at a desired significance level. As a consequence, the type I error spending function will be altered from the one chosen for the design, thus affecting the operating characteristics of the subsequent group sequential logrank tests. In maximum information trials, however, the maximum amount of information is fixed, and thus the estimate of the information time is always unbiased. The net effect is that computation of group sequential boundaries becomes straightforward, with a potential saving in study durations as compared to maximum duration trials. We will illustrate how adjustments are made in maximum duration trials to maintain type I error when the information times are estimated with the information horizons under the null and alternative hypotheses and present numerical explorations to compare robustness of two different estimates of the information times. We then propose a design procedure for maximum information trials and investigate the properties of maximum information trials for different group sequential boundaries. We also compare maximum information trials and maximum duration trials based on an example.

摘要

当使用对数秩检验和I型错误消耗函数方法监测具有失效时间数据的临床试验时,信息时间必须估计为最大失效数的一部分。在最大持续时间试验中,该分数的分母是一个随机量,必须进行估计;此外,分母有两个候选值,一个在无治疗差异的原假设下,另一个在指定的备择假设下。无论哪种方式,在确定组序贯边界时都需要进行一些调整,以将I型错误维持在期望的显著性水平。因此,I型错误消耗函数将与设计时选择的函数不同,从而影响后续组序贯对数秩检验的操作特性。然而,在最大信息试验中,最大信息量是固定的,因此信息时间的估计始终是无偏的。其净效应是组序贯边界的计算变得直接,与最大持续时间试验相比,有可能节省研究持续时间。我们将说明在最大持续时间试验中,当根据原假设和备择假设下的信息范围估计信息时间时,如何进行调整以维持I型错误,并进行数值探索以比较信息时间的两种不同估计的稳健性。然后,我们提出一种最大信息试验的设计程序,并研究不同组序贯边界的最大信息试验的性质。我们还基于一个例子比较最大信息试验和最大持续时间试验。

相似文献

1
Design and analysis of group sequential logrank tests in maximum duration versus information trials.最大持续时间与信息量试验中序贯对数秩检验的设计与分析
Biometrics. 1995 Sep;51(3):988-1000.
2
Implementation of group sequential logrank tests in a maximum duration trial.在最大持续时间试验中实施组序贯对数秩检验。
Biometrics. 1990 Sep;46(3):759-70.
3
Use of logrank tests and group sequential methods at fixed calendar times.在固定日历时间使用对数秩检验和序贯分组方法。
Biometrics. 1985 Dec;41(4):1039-44.
4
Implementing type I & type II error spending for two-sided group sequential designs.在双侧成组序贯设计中实施I型和II型错误消耗。
Contemp Clin Trials. 2008 May;29(3):351-8. doi: 10.1016/j.cct.2007.09.002. Epub 2007 Sep 21.
5
Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.使用期中 Z 值或置信限控制 I 型和 II 型错误概率的无效性期中监测。
Clin Trials. 2009 Dec;6(6):565-73. doi: 10.1177/1740774509350327. Epub 2009 Nov 23.
6
A group-sequential design for clinical trials with treatment selection.一种用于有治疗选择的临床试验的序贯分组设计。
Stat Med. 2008 Dec 20;27(29):6209-27. doi: 10.1002/sim.3436.
7
Exact permutational tests for group sequential clinical trials.成组序贯临床试验的精确置换检验
Biometrics. 1994 Dec;50(4):1042-53.
8
Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.基于序贯条件概率比检验和反向随机截尾的临床试验设计。
Biometrics. 1998 Jun;54(2):682-95.
9
Study duration for clinical trials with survival response and early stopping rule.具有生存反应和早期终止规则的临床试验的研究持续时间。
Biometrics. 1990 Mar;46(1):81-92.
10
Sequential analysis of censored survival data from three treatment groups.来自三个治疗组的删失生存数据的序贯分析。
Biometrics. 1997 Sep;53(3):807-22.

引用本文的文献

1
Information fraction estimation: Strategies for a phase 3 non-inferiority maximum duration design with time to event outcome.信息分数估计:具有事件时间结局的 3 期非劣效最大持续时间设计的策略。
Pharm Stat. 2023 Nov-Dec;22(6):1031-1045. doi: 10.1002/pst.2327. Epub 2023 Jul 26.
2
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order.创新肌萎缩侧索硬化症临床试验:挑战既定秩序。
Neurology. 2021 Sep 14;97(11):528-536. doi: 10.1212/WNL.0000000000012545. Epub 2021 Jul 27.